For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News
COVID-19 Herbs: A new study by American researchers from Eastern Virginia Medical School-Virginia, Rush University Medical Center-Illinois and Loyola University Chicago- Illinois has found that the phytochemical ginkgolic acid that is obtained from gingko biloba shows promising prospects as an antiviral to treat COVID-19 after finding that it was able to inhibit the infection of the coronavi...
Source: COVID-19-Autoimmune Diseases Sep 26, 2021 3 years ago
COVID-19 And Autoimmune Diseases: Various new studies are showing that an infection with the SARS-CoV-2 can also trigger a variety of autoimmune conditions and diseases including some never seen before.
In the first study by researchers from Stanford University School of Medicine-USA, the study team found that in severe hospitalized COVID-19 patients, the immune system is tricked into prod...
Source: COVID-19 Research Sep 26, 2021 3 years ago
COVID-19 Research: Day by day newer study findings and data are emerging that gives us a more detailed perspective about the COVID-19 disease caused by the SARS-CoV-2 coronavirus. Some of these findings add to the list of things that we already know while some supersede previous assumptions or weak study findings about the pathogenesis of the SARS-CoV-2 virus and the human host cellular pathway re...
Source: Emerging Delta Sub-Variants-AY.29 Sep 25, 2021 3 years ago
Thailand Medical News is warning that a new Delta sub-variant called AY.29 with two more distinct mutations on it ie C5239T And T5514C that most probably became predominant in Japan in June 2021 could be more transmissible.
We are also warning that new mutations have been found on this new lineage ie C28170T (ORF8: P93S) and C5365T mutations since August 2021 and these new evolved forms of...
Source: COVID-19 Research Sep 25, 2021 3 years ago
COVID-19 Research: A new study led by researchers from University of Kent-UK and Goethe University-Germany has discovered that a protein that is a component of the human immune system called CD47, found on cell surfaces plays a contributing factor to COVID-19 disease severity.
Typically most SARS-CoV-2 infections are mild or even asymptomatic. However, a small fraction of infected individu...
COVID-19 Exposé : First it was the Trump Administration along with the U.S.NIH or to be specific the NIAID headed by Anthony Fauci that poured millions of dollars in to the development and research of the overpriced drug remdesivir that is not only hepatoxic but also nephrotoxic to treat COVID-19. There are tons of studies that confirm its toxicity issues, these are just a few.
http...
COVID-19 News: A new study by researchers from the Genos Glycoscience Research Laboratory-Croatia and the University of Zagreb-Croatia has shockingly found that the SARS-CoV-2 coronavirus is able to not just bind to the ACE2 receptors but also are able to bind to 13 other identified human host receptors.
These host receptors include:
1. C-type lectin receptors
2. Mannose-binding lec...
Source: Guillain-Barré Syndrome and COVID-19 Sep 23, 2021 3 years ago
Guillain-Barré Syndrome and COVID-19: A new international collaborative study has confirmed that SARS-CoV-2 infections can trigger Guillain-Barré Syndrome.
Guillain-Barré syndrome (GBS) is a rare, autoimmune disorder in which a person's own immune system damages the nerves, causing muscle weakness and sometimes paralysis. GBS can cause symptoms that ...
Source: SARS-CoV-2 R.1 Variant Sep 23, 2021 3 years ago
R.1 Variant: A new SARS-CoV-2 variant called R.1 has reemerged after months of gaining viral fitness and relevant mutations on its genome to make it truly virulent, potent, extremely transmissible and immune evasive. The R.1 may be easier to contract due to protein mutations within the spike protein of the virus and its ability to be easily transmitted from person to person despite vaccination sta...
COVID-19 Drugs: A researcher from the University of Lahore Pakistan has proposed that the drug aprepitant could be used to target the neurokinin-1 receptors to prevent COVID-19 cytokine storms.
Aprepitant is a medication used in the management and treatment of chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV). It is in the neurokinin-1 a...
Cancer-News: A new study by researchers from the University of Sydney-Australia has shown that the phytochemical Erianin extracted from a commonly cultivated orchid could be a potential new treatment option for prostate cancer.
Dendrobium chrysotoxum
The phytochemical erianin, is a natural plant-derived bibenzyl compound, present in Dendrobium chrysotoxum, an orchid species native to S...
Source: America Medical News Sep 22, 2021 3 years ago
U.S. Medical News: American media are reporting that for the first time since early March 2021, COVID-19 death rates are once again climbing in the country with daily rates now topping almost 1,900.
As of today, (22nd September, 2021) according to statistics from Worldometer site, more than 43.2 million Americans have been infected with the SARS-CoV-2 coronavirus and more than 696,867 Amer...
Source: COVID-19 Immunology Sep 22, 2021 3 years ago
COVID-19 Immunology: A new study by researchers from Cedars-Sinai Medical Center-California not only confirms that SARS-CoV-2 infections whether symptomatic (Be it Mild, Moderate or Severe) or even asymptomatic can generate distinct autoantibodies that can lead to a variety of autoimmune issues not only during the infection stage but also in the long term. The study has also found that males tend ...
Source: COVID-19 Research Sep 21, 2021 3 years ago
COVID-19 Research: A new study led by German researchers from the Center for Infection and Genomics of the Lung (CIGL), Universities of Giessen and Marburg Lung Center, Giessen-Germany along with scientist from numerous other German research institutions have shockingly found that the SARS-CoV-2 induces the formation of unique and different and fibrin clot structures never seen before in the human...
Medical News: For a long time now, a lot of research on the SARS-CoV-2 coronavirus mode of infection and pathogenesis has only been focuses on the spike proteins with very little paid to the rest of the proteins found on the viral genome.
A new study by German scientists from Berlin Institute for Medical Systems Biology and the Max Delbrück Center for Molecular Medicine-Berlin and the...
B.1.1.519 Variant Researchers are warning that the Mexican variant B.1.1.519 which has been ravaging Mexico for a few months now not only causes an increased risk of hospitalization and disease severity but also increased the risk of mortality. Further just like the Delta and Mu variants, it is spawning sub-variants that are of concern.
Two studies have already been published by Mexican re...
Source: COVID-19 Immunology Sep 20, 2021 3 years ago
COVID-19 Immunology: A new study by led by researchers from University of Amsterdam-Netherlands along with support by scientists from Weill Medical College of Cornell University-USA has found that SARS-CoV-2 infections typically activate the human dendritic cells via cytosolic receptors rather than by extracellular Toll-like receptors (TLRs).
Typically, the human immune system needs to rec...
Source: COVID-19 Mortality Sep 20, 2021 3 years ago
COVID-19 Mortality: A new research led by scientist from Oxford University-UK that also involved researchers from St. George’s University of London-UK, St. George’s Hospital NHS Trust-UK and the Massachusetts Institute of Technology-USA has found that most fatal COVID-19 cases are due to weak immune responses and elevated MAIT(elevated mucosal associated invariant) cell acti...
Long COVID News: A new study led by researchers from Columbia University-USA along with support of scientists from the Zan Mitrev Clinic-North Macedonia and University of Florence-Italy has found that Long-COVID is associated with sustained biochemical disturbances especially elevated levels of D-dimers and Ferritin.
The Study team aimed to evaluate the incidence of Post-Acute Sequelae of ...
Source: SARS-CoV-2 Variants Sep 19, 2021 3 years ago
SARS-CoV-2 Variants: A new study by Taiwanese researchers from the Academia Sinica and National Taiwan University along with support by scientists from the Medical University of Lublin-Poland and Johns Hopkins University-USA has found that the different SARS-CoV-2 variants not only have different mutations and deletions on them but most importantly they exhibit different but unique spike str...
Source: Sunday COVID-19 Briefs Sep 19, 2021 3 years ago
Sunday COVID-19 Briefs
WHO While Encouraging Vaccination, Refuses To Reveal Vaccination Data Of Its Own Staff
WHO, a United Nations' health agency, which has repeatedly urged the world to get vaccinated against COVID-19 and other illnesses, on Friday declined to say how many of its own staffers have followed that advice.
Dr Margaret Harris, a World Health Organization spo...
Source: COVID-19 Supplements-Flavonoids Sep 18, 2021 3 years ago
COVID-19-Supplements: As part of Thailand Medical News continued initiatives on herbs and phytochemical research for treating COVID-19 and also Long COVID, the following coverage on the usage of herbs and phytochemicals to treat COVID-19 and a health conditions arising with the novel coronavirus infection or what is termed as Long COVID or PASC (Post-acute Sequelae of COVID-19) shows the growing i...
Source: SARS-CoV-2 Variants Sep 18, 2021 3 years ago
SARS-CoV-2 Variants: French researchers in a new study have identified a new Delta sub-variant that is of concern as it not only possess the unique mutation S:E484Q found on the Kappa variant but it also has the S:T95I mutation found on the Iota variant that is associated with breakthrough infections!
Alarmingly other mutations were also found on the new Delta sub-variant phylogenetic clus...
Source:Hypertension And mRNA Vaccines Sep 18, 2021 3 years ago
A study by researchers from Lausanne University Hospital-Switzerland has found that an extremely small percentage of otherwise healthy individuals who receive the mRNA vaccines such as those by Pfizer or Moderna, run the risk of developing stage III hypertension upon vaccination.
The study findings were published in the peer reviewed journal: Hypertension (A Journal of the American Heart Associat...
UPDATED 17th October 2021:After the publication of our article on September 17th, numerous researchers responded and a team from Washington University in St. Louis, University of Illinois and Harvard University got together to conduct a detailed study which confirms that the COVID-19 vaccines does cause increased menstrual bleeding and also disrupts and causes irregular menstruation periods.
 ...
Source: SARS-CoV-2 Airborne Sep 17, 2021 3 years ago
SARS-CoV-2 Airborne: As predicted by Thailand Medical News in our earlier coverage, study findings by researchers from the University of Maryland shows that the SARS-CoV-2 coronavirus is evolving to become even better at airborne transmissions.
To date, SARS-CoV-2 epidemiology implicates airborne transmission but aerosol infectiousness and impacts of masks and variants on aerosol shedding ...
Source: COVID-19 Research Sep 17, 2021 3 years ago
COVID-19 Research: A new private study by researchers from Vanda Pharmaceuticals Inc, a global biopharmaceutical company focused on the development and commercialization of innovative therapies located in Washington DC-USA has uncovered that the chemokine receptor and the chemokine CXCR6/CXCL16 plays a key role in the in the immuno-pathogenesis of severe COVID-19.
 ...
Long COVID News: A new study by researchers from the University of Texas-Arlington shows that young and otherwise healthy adults would suffer persistent peripheral macrovascular and microvascular complications following ‘recovery’ from COVID-19.
The study was the first to investigate the persistent effects of COVID-19 on vascular function in otherwise healthy young adults.
&nbs...
Source: COVID-19-Myocarditis Sep 16, 2021 3 years ago
COVID-19 and Myocarditis: A new study by researchers from the Drug Safety Research Unit, Southampton-UK and the School of Pharmacy and Biomedical Sciences, University of Portsmouth-UK warns about the occurrences of myocarditis and pericarditis in men following mRNA-based COVID-19 vaccination. Though considered rare events, the number of cases being reported worldwide is of a concern.
The s...
COVID-19 Drugs: The phase 1a clinical trial led by researchers from the University of Liverpool-UK using the antiparasitic drug Nitazoxanide has shown potential in terms of treating the COVID-19 disease. The research team also comprised clinicians and scientist from University of Southampton-UK, University of Cambridge-UK, the Liverpool School of Tropical Medicine-UK and the Liverpool University H...
Source: COVID-19 Supplements-Quercetin Sep 15, 2021 3 years ago
COVID-19 Supplements: Since Thailand Medical News first covered a collection of studies in August 2020 showing that Quercetin could be used as adjuvant to treat COVID-19, its effectiveness has since been proven in many subsequent studies and even randomized clinical trials. https://www.thailandmedical.news/news/breaking-supplements-for-covid-19-quercetin-emerging-as-an-adjuvant-for-covid-19-treatm...
Source: Diets And Nutrition Sep 15, 2021 3 years ago
Diets And Nutrition: A new study led by researchers from the University of Illinois, Urbana-USA along with scientists from the University of Florida-USA and the University of Roehampton-UK have found that daily consumption of avocados by females helps them redistribute abdominal body fat and also helps them maintain insulin sensitivity and proper insulin health.
Though the consumption of a...
Source: New SARS-CoV-2 Variants Sep 15, 2021 3 years ago
New SARS-CoV-2 Variants: Researchers from the City University of New York, University of Missouri-School of Medicine and The New School-New York (A private university) have in a new study alarmingly come across four new unique “cryptic” lineages of the SARS-CoV-2 coronavirus ie WNY1, 2, 3, and 4, from wastewater sites. Shockingly these new variants had an assortment of mutations ...
Source: COVID-19-Innovations Sep 14, 2021 3 years ago
COVID-19 Innovations: Scientist from Ohio State University along with researchers from the Ford Research and Innovation Center-Michigan have in a new study explored the use of heat treatments to inactivate SARS-CoV-2 in passenger vehicles including cars, van and buses.
According to the study abstract, “Heat is an established method to inactivate coronaviruses, and there is utility in...
Source: Thailand Coronavirus News Sep 14, 2021 3 years ago
Thailand Coronavirus News: A very strange and confusing thing happened yesterday, local Thai health officials released data to the media saying that of those who died from COVID-19, 14.4% had already received the first dose of the COVID-19 vaccine.
Perhaps they were trying to point to the fact that a single dose of COVID-19 vaccine does not guarantee survival if infected. However various c...
Medical Alert: Yet another alarming study finding on the multitude of negative effects that the novel coronavirus has on the human host, this time from a research by scientist from Yale University School of Medicine, Icahn School of Medicine at Mount Sinai, and Iowa State University. The research findings reveals that the SARS-CoV-2 coronavirus expresses a microRNA or miRNA called vmiR-5p that is ...
Long-COVID News: Scientists from the University of Vermont-USA along with support from researchers from Duke University School of Medicine-North Carolina-USA have in a new study confirmed that the SARS-CoV-2 coronavirus has the ability able to cause damage to the DNA and telomeres of the human host. The study findings has alarming implications in terms of long term medical conditions and also help...
COVID-19 News: A new study led by Brazilian researchers from the University of São Paulo that also included scientists from the University of Campinas, Universidade do Estado do Amazonas, Universidade Federal do Amazonas, Hospital Israelita Albert Einstein and other institutions have found that acid pH enhances SARS-CoV-2 infection by up-regulating the ACE2 receptors and found that individu...
Source: A Letter To Thailand Medical News Sep 12, 2021 3 years ago
A Letter To Thailand Medical News: The world is getting crazy day by day all because of those controlling the COVID-19 narratives. I am all for vaccines but vaccines that fully work and are 100% safe. Not vaccines that cannot stop the spread of a disease. Not vaccines that allow breakthrough infections. And certainly note that vaccines that cannot stop disease severity, hospitalizations and mortal...
Source: SARS-CoV-2 Research Sep 12, 2021 3 years ago
SARS-CoV-2 Research: Chinese scientist from Shandong University in Jinan-China have discovered that the SARS-CoV-2 ORF9b proteins are able to inhibit type I and III interferon (IFN) response and production by targeting various components of various immune signaling pathways.
The study findings were published in the peer reviewed Journal of Medical Virology. https://onlinelibrar...
Source: Latest COVID-19 Research Sep 12, 2021 3 years ago
Latest COVID-19 Research: Chinese researchers from Nanjing University, Wuhan Institute of Virology, National Center of Gerontology at Beijing Hospital and the Army Engineering University of PLA have in a new breakthrough study identified 4 human host exosomal miRNAs that possess antiviral properties and are able to inhibit the SARS-CoV-2 coronavirus. Furthermore it was found that varying amounts o...
Source: COVID-19 Research Sep 11, 2021 3 years ago
COVID-19 Research: A new breakthrough study by scientist from New York University Grossman School of Medicine has found SARS-CoV-2 induced hyperactive platelets’ unique genes S1000A8 and S1000A9 causes the platelets to produce more myeloid-related proteins (MRP) 8 and 14 that contribute to increased inflammation, clotting, disease severity and longer hospital stays. The study also show...
Source: India Medical News Sep 11, 2021 3 years ago
India Medical News: India’s Prime Minister Narendra Modi on Friday (10th September 2021) chaired a high-level meeting on the COVID situation, preparations and vaccination status as the government noted high caseloads in states like Kerala and Maharashtra. A government spokesman on conditions of anonymity said that the meeting was called for urgently as there has been ‘domestic and...
Source: Mu Variant B.1.621 Sep 11, 2021 3 years ago
Mu variant: Physicians from various hospitals in Massachusetts are warning that COVID-19 patients infected with the SARS-CoV-2 Mu variant are appearing in many hospitals in the state, indicating that the Mu variant is fast spreading. They urge more close monitoring and extra vigilance as the variant could take over the Delta variant as the dominant strain in a matter of weeks.
Many ex...
Source: COVID-19 Symptoms Sep 10, 2021 3 years ago
COVID-19-Symptoms: A new study by researchers from the Laboratory of Oral Histopathology, Health Sciences Faculty, University of Brasilia-Brazil has found that dry mouth or Xerostomia is another new symptom of experienced by those with COVID-19. Dry mouth is also a more common symptom in those infected with the Delta variants according to sources not involved with the study.
The stud...
Long-COVID: The COVID-19 pandemic is an extremely dynamic event in which new and better evolving research are constantly materializing and superseding whatever we had earlier known along with the fact that there are constantly new players in the pandemic due to the variety of emerging SARS-CoV-2 variants, each with unique mutations, characteristics, pathogenesis and their own specific manner of di...
Source: Probiotics and COVID-19 Sep 09, 2021 3 years ago
Probiotics-COVID-19: A new study by Italian researchers from the University of Rome and the University of L’Aquila has found that oral bacteriotherapy involving probiotics comprising of lactic acid bacteria and bifidobacteria not only decreases the risk of respiratory failure in COVID-19 but it also decreases the risk of disease severity and also the need for hospitalization. Oral admin...
Source: Pediatric COVID-19 Sep 09, 2021 3 years ago
Pediatric COVID-19: Researchers from the Pediatric Neurology Unit at the Hadassah Medical Center-Israel and the School of Medicine at the Hebrew university of Jerusalem-Israel have in a clinical study found that seizures are a manifestation of severe SARS-CoV-2 infection in children.
The study team conducted a systematic retrospective study to identify all children who presented to the eme...
Source: Mu or B.1.621 variant Sep 08, 2021 3 years ago
New alarming study findings by Japanese researchers from the University of Tokyo, Kyoto University, Chiba University and Tokai University have shown and confirmed that convalescent and vaccine sera has little or no effect on the fast globally spreading Mu SARS-CoV-2 variants.
The study findings were published on a preprint server and are currently being peer reviewed. https://www.bio...
Source: SARS-CoV-2 Delta Variant Sep 08, 2021 3 years ago
The largest ever and detailed study led by researchers from the University of Cambridge along with scientists and experts from University College London-UK, National Centre for Disease Control-India, CSIR Institute of Genomics and Integrative Biology-India ,Imperial College London-UK,Sri Ganga Ram Hospital-India, Indraprastha Apollo Hospital-India. The Genotype to Phenotype Japan (G2P-Japan)...
IBD-COVID-19: A new study by researchers from Israel has found that patients with inflammatory bowel disease (IBD) taking tumor necrosis factor (TNF) α inhibitors will experience decreased COVID-19 vaccine efficacy.
The study findings were published on a preprint server and are currently being peer reviewed.
It is already known that IBD patients treated with immunomodulatory d...
Source: COVID-19-Nipah Virus Sep 07, 2021 3 years ago
India Medical News: Kerala, an Indian Southern state has reported an outbreak of the Nipah Virus as it is still struggling with the COVID-19 crisis due to the fast spreading Delta variant.
In the last 24 hours alone, the Indian state of Kerala recorded a total of 19,688 new COVID-19 infections and 135 COVID-19 deaths.
Health and government authorities in Kerala quickly ramping up ef...
Source: COVID-19 Research Sep 07, 2021 3 years ago
COVID-19 Research: Yet another alarming study finding has emerged from a research by scientists from the Fred Hutchinson Cancer Research Center-Seattle and the institute for Systems Biology-Seattle in which it has been found that the SARS-CoV-2 coronavirus is able to cause metabolic changes to the plasma and immune cells of the human host!
Furthermore the study findings also show that these chang...
Lambda variant: A new study by researchers from the Department of Immunology and Genomic Medicine, National Jewish Health-Denver and the Department of Immunology and Microbiology, School of Medicine, Anschutz Medical Center, University of Colorado-USA along with scientists from the State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agriculture University, Beijing...
NeuroCOVID: New alarming study findings by researchers from the Ruđer Bošković Institute-Croatia, University of Zagreb-Croatia and the National Institute of Chemistry- have shown that the Spike proteins of the SARS-CoV-2 coronavirus have a strong biding affinity for the enzyme found in the brain called monoamine oxidases (MAO) enzymes and it is as a result of these binding and su...